Modeling simian immunodeficiency virus (SIV) latency in primary rhesus macaque CD4+ T cells
Matschke, L. M.; Reynolds, M. R.
Show abstract
Simian immunodeficiency virus (SIV)-infected rhesus macaques are valuable models for HIV cure research, offering insights into tissue reservoirs and testing reservoir-reduction strategies. Despite this utility, low frequencies of latently infected cells in vivo limit mechanistic studies of viral latency ex vivo. In vitro latency models have addressed this limitation for HIV, advancing our understanding of viral persistence. However, no comparable models exist for SIV. To address this gap, we developed an in vitro model of SIV latency in primary rhesus macaque CD4+ T cells, optimizing conditions to promote viral entry while maintaining cells in a minimally activated, non-proliferating state. After 12 days in culture, [~]1-3.3% of cells harbored SIV DNA, primarily as intact proviruses within central and transitional memory CD4+ T cell subsets. These cells remained quiescent, exhibiting minimal spontaneous viral protein production, but could be reactivated by potent T-cell stimulation and benchmark latency-reversing agents. Collectively, this model generates SIV-latently infected cells that resemble predominant cellular reservoirs in vivo--quiescent memory CD4+ T cells carrying inducible proviruses. This system provides a platform for investigating mechanisms of SIV latency, identifying shared and virus-specific features of HIV and SIV persistence, and evaluating strategies to reactivate or silence viral reservoirs. ImportanceViral latency-HIVs ability to persist in a dormant state within CD4+ T cells-remains a critical barrier to developing a cure. Rhesus macaques infected with simian immunodeficiency virus (SIV) are valuable models for studying HIV, but mechanistic studies of viral persistence are limited by the low frequency of latently infected cells in vivo. While in vitro models have advanced our understanding of HIV latency, comparable tools for studying SIV were lacking. To address this gap, we established a novel model of SIV latency using rhesus macaque CD4+ T cells, mirroring key features of natural reservoirs. This model provides a platform for studying how viral latency is established and maintained, conducting direct comparisons between HIV and SIV infections, and evaluating potential cure strategies.
Matching journals
The top 5 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Th17 cell master transcription factor RORC2 regulates HIV-1 gene expression and viral outgrowth 96%
- Monocyte to macrophage differentiation and changes in cellular redox homeostasis promote cell type-specific HIV latency reactivation 96%
- Longitudinal clonal dynamics of HIV-1 latent reservoirs measured by combination quadruplex polymerase chain reaction and sequencing 96%
Similar papers in this journal
- The combination of three CD4-induced antibodies targeting highly conserved Env regions with a small CD4-mimetic achieves potent ADCC activity 96%
- Impact of suboptimal APOBEC3G neutralization on the emergence of HIV drug resistance in humanized mice 96%
- Human cytomegalovirus-encoded G protein-coupled receptor (GPCR), UL78, regulates viral reactivation 96%
Similar papers in this journal
- HIV-1 accessory protein Vpr possesses a cryptic p300-dependent transcription-promoting activity that is blocked by histone deacetylases in CD4+ T cells. 97%
- Release of P-TEFb from the Super Elongation Complex promotes HIV-1 latency reversal 97%
- Rapid progression is associated with lymphoid follicle dysfunction in SIV-infected infant rhesus macaques 96%
Similar papers in this journal
- B Lymphocytes, But Not Dendritic Cells, Efficiently HIV-1 Trans-Infect NaïVe Cd4+ T Cells: Implications For The Viral Reservoir 97%
- Exploiting rodent cell blocks for intrinsic resistance to HIV-1 gene expression in human T cells 96%
- HIV-1 Vpr-induced DNA damage activates NF-κB through ATM-NEMO independent of cell cycle arrest 96%
Similar papers in this journal
- Hydrogen sulfide blocks HIV rebound by maintaining mitochondrial bioenergetics and redox homeostasis 96%
- The anti-caspase 1 inhibitor VX-765 reduces immune activation, CD4+ T cell depletion, viral load and total HIV-1 DNA in HIV-1 infected humanized mice 95%
- Persistence of intact HIV-1 proviruses in the brain during antiretroviral therapy 95%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.